Preventing Recurrences: Classic and Modern Antiarrhythmic Drugs in Atrial

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Unknown venue

• Publication date

  2015-01-22

• Fields of study

  Medicine

• Identifiers
  DOI 10.4172/2329-6607.1000130
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Interventions for the treatment of atrial fibrillation: a systematic literature review and meta-analysis.

  2013cited by this paper
• Short-term versus long-term antiarrhythmic drug treatment after cardioversion of atrial fibrillation (Flec-SL): a prospective, randomised, open-label, blinded endpoint assessment trial.

  2012cited by this paper
• Dronedarone in high-risk permanent atrial fibrillation.

  2012cited by this paper
• 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (Updating the 2006 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

  2011cited by this paper
• Mixed treatment comparison of dronedarone, amiodarone, sotalol, flecainide, and propafenone, for the management of atrial fibrillation.

  2011cited by this paper
• 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (updating the 2006 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

  2011cited by this paper
• A randomized active-controlled study comparing the efficacy and safety of vernakalant to amiodarone in recent-onset atrial fibrillation.

  2011influential reference
• Late Sodium Current Contributes to the Reverse Rate-Dependent Effect of IKr Inhibition on Ventricular Repolarization

  2011cited by this paper
• Trends in US Hospitalization Rates and Rhythm Control Therapies Following Publication of the AFFIRM and RACE Trials

  2011cited by this paper
• A Short‐Term, Randomized, Double‐Blind, Parallel‐Group Study to Evaluate the Efficacy and Safety of Dronedarone versus Amiodarone in Patients with Persistent Atrial Fibrillation: The DIONYSOS Study

  2010cited by this paper
• Synergistic effect of the combination of ranolazine and dronedarone to suppress atrial fibrillation.

  2010cited by this paper
• A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey.

  2010cited by this paper
• Comparative Efficacy of Dronedarone and Amiodarone for the Maintenance of Sinus Rhythm in Patients With Atrial Fibrillation

  2010cited by this paper
• Synergistic Electrophysiologic and Antiarrhythmic Effects of the Combination of Ranolazine and Chronic Amiodarone in Canine Atria

  2010cited by this paper
• Guías de práctica clínica para el manejo de la fibrilación auricular

  2010cited by this paper
• Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).

  2010cited by this paper
• Vernakalant Hydrochloride for the Rapid Conversion of Atrial Fibrillation After Cardiac Surgery: A Randomized, Double-Blind, Placebo-Controlled Trial

  2009cited by this paper
• Effect of dronedarone on cardiovascular events in atrial fibrillation.

  2009cited by this paper
• Analysis of Stroke in ATHENA: A Placebo-Controlled, Double-Blind, Parallel-Arm Trial to Assess the Efficacy of Dronedarone 400 mg BID for the Prevention of Cardiovascular Hospitalization or Death From Any Cause in Patients With Atrial Fibrillation/Atrial Flutter

  2009cited by this paper
• Vernakalant Hydrochloride for Rapid Conversion of Atrial Fibrillation: A Phase 3, Randomized, Placebo-Controlled Trial

  2008influential reference
• A preliminary assessment of the effects of ATI-2042 in subjects with paroxysmal atrial fibrillation using implanted pacemaker methodology

  2008cited by this paper
• Increased mortality after dronedarone therapy for severe heart failure.

  2008cited by this paper
• Stroke and thromboembolism in atrial fibrillation: A systematic review of stroke risk factors, risk stratification schema and cost effectiveness data

  2008cited by this paper
• Continuous vs episodic prophylactic treatment with amiodarone for the prevention of atrial fibrillation: a randomized trial.

  2008cited by this paper
• Amiodarone Interacts with Simvastatin but not with Pravastatin Disposition Kinetics

  2007cited by this paper
• Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.

  2007cited by this paper
• Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter.

  2007cited by this paper
• Antiarrhythmic drugs for maintaining sinus rhythm after cardioversion of atrial fibrillation: a systematic review of randomized controlled trials.

  2006cited by this paper
• RSD1235 blocks late INa and suppresses early afterdepolarizations and torsades de pointes induced by class III agents.

  2006cited by this paper
• An Argument for Maintenance of Sinus Rhythm in Patients With Atrial Fibrillation

  2005cited by this paper
• Amiodarone versus sotalol for atrial fibrillation.

  2005cited by this paper
• Is rate control or rhythm control preferable in patients with atrial fibrillation? An argument for maintenance of sinus rhythm in patients with atrial fibrillation.

  2005cited by this paper
• Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy.

  2005cited by this paper
• Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation: the results of the Polish How to Treat Chronic Atrial Fibrillation (HOT CAFE) Study.

  2004cited by this paper
• Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial.

  2004cited by this paper
• A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation

  2003cited by this paper
• Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study.

  2003cited by this paper
• Sotalol testing unmasks altered repolarization in patients with suspected acquired long-QT-syndrome--a case-control pilot study using i.v. sotalol.

  2003cited by this paper
• A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation.

  2002cited by this paper
• A comparison of rate control and rhythm control in patients with atrial fibrillation.

  2002cited by this paper
• Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators.

  2000cited by this paper
• Efficacy and Safety of Oral Dofetilide in Converting to and Maintaining Sinus Rhythm in Patients With Chronic Atrial Fibrillation or Atrial Flutter: The Symptomatic Atrial Fibrillation Investigative Research on Dofetilide (SAFIRE-D) Study

  2000cited by this paper
• Rhythm or rate control in atrial fibrillation--Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial.

  2000cited by this paper
• Amiodarone to prevent recurrence of atrial fibrillation.

  2000cited by this paper
• Effect of dofetilide in patients with recent myocardial infarction and left-ventricular dysfunction: a randomised trial.

  2000cited by this paper
• The potential for QT prolongation and pro-arrhythmia by non-anti-arrhythmic drugs: clinical and regulatory implications. Report on a Policy Conference of the European Society of Cardiology.

  2000cited by this paper
• The potential for QT prolongation and proarrhythmia by non-antiarrhythmic drugs: clinical and regulatory implications. Report on a policy conference of the European Society of Cardiology.

  2000cited by this paper
• Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group.

  1999cited by this paper
• Effect of atrial fibrillation on atrial refractoriness in humans.

  1996cited by this paper
• Effects of verapamil and propranolol on early afterdepolarizations and ventricular arrhythmias induced by epinephrine in congenital long QT syndrome.

  1995cited by this paper
• Mortality following ventricular arrhythmia suppression by encainide, flecainide, and moricizine after myocardial infarction. The original design concept of the Cardiac Arrhythmia Suppression Trial (CAST).

  1993cited by this paper
• Tachycardia-induced cardiomyopathy: a reversible form of left ventricular dysfunction.

  1986cited by this paper
• Classification of antiarrhythmic drugs

  1975cited by this paper

• On mechanism of antiarrhythmic action of some dimethylphenylacetamide derivatives

  2018cites this paper
• Comparison between Carotid Artery Doppler Ultrasound and Coronary Calcium Score as Predictors of Significant Coronary Artery Disease in Patients Undergoing Computed Tomography Coronary Angiography

  2014cites this paper